Chemist Warehouse sales, profit surge ahead of ASX debut

Sigma Healthcare has pointed to its improved turnover as proof that its merger with Chemist Warehouse will not stifle competition in Australia’s pharmacy sector, and it hopes to secure the competition regulator’s approval in the second half for their $8.8 billion listed giant.

The ASX-listed drug wholesaler and Chemist Warehouse revealed a friendly plan to merge in December. The deal requires the approval of the Australian Competition and Consumer Commission, which started a consultation in March. The Pharmacy Guild opposes it.